Us And Canada

Corporates hit Click in $19m round
Drug developers Sanofi and Hikma both contributed to a funding round for health management app developer Click Therapeutics to bring its total financing to more than $26m.
Corporates see Sense for $18m series B
Household energy monitor developer Sense has expanded its overall funding to almost $39m in a round backed by Schneider Electric and existing investors Shell and iRobot.
CrowdStrike considers 2019 IPO
The endpoint security software producer has hired Goldman Sachs for an initial public offering that would enable Alphabet, Rackspace and Telstra to exit.
Vector successfully angles for $70m series B
Kanematsu-backed microsatellite launch services provider Vector has collected $70m in a series B round that brought its total funding to more than $100m.
Vacasa books into $64m round
Vacasa has added $64m in an Assurant-backed round that will help the holiday property manager pursue further domestic and international expansion.
TP Therapeutics tops series C with $80m
The cancer therapy developer has raised $80m in a mezzanine round that came almost 18 months after its series C, with Lilly Asia Ventures and SR One backing both rounds.
Revolution acquires Warp Drive to accelerate progress
Warp Drive Bio, the genomic medicine developer co-founded by Sanofi, has agreed to an all-share acquisition by Revolution Medicines.
CuraSen lures Johnson & Johnson to series A
Johnson & Johnson Innovation – JJDC was among the investors in CuraSen Therapeutics' $54.5m series A round, which was led by New Leaf Venture Partners.

Other News

Microsoft returns to WhiteSource for $35m round
Open-source cybersecurity software provider WhiteSource has raised cash in a series C round led by Susquehanna Growth Equity that included Microsoft's M12 unit.
Tastemade cooks up $35m in funding
Amazon and existing backer Comcast both invested in a round that boosted lifestyle media platform Tastemade's total funding to $115m.
Corporate venturing deal net: 15-19 October 2018
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Palantir puts 2019 IPO on the plate
The Relx-backed data miner could double its valuation to $41bn in the proposed offering, according to prospective underwriters.
SI-Bone burrows into public markets with $108m IPO
The Novo-backed surgical implant provider floated at the top of its range and increased the number of shares in the offering.
Cloud9 beams up $50m
The eSports team manager has added series B funding to a 2017 series A backed by WWE, FunPlus, Beverly Hills Sports Council and UTA Ventures.

Editor's Picks

Palantir puts 2019 IPO on the plate
The Relx-backed data miner could double its valuation to $41bn in the proposed offering, according to prospective underwriters.
Instacart bags up $600m
The grocery delivery service, which counts Amazon, American Express and Comcast as investors, has increased its valuation 75% to $7.6bn in just six months.
Taiho takes corporate venturing fund to $300m
Taiho Ventures, launched two years ago with $50m in capital, has had its reserves expanded by a further $250m as Taiho Pharmaceuticals looks to enhance its open innovation work.
Allogene rallies to $324m IPO
The Pfizer and Gilead-backed immuno-oncology therapy developer, which had raised $300m in an April series A round, floated at the top of its range.
test reg


Not yet subscribed?

See your subscription offers here